PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
18-Sep-2020 Positive clinical results for TG4001 and TG6002 and financial visibility secured until 2022 Transgene
18-Sep-2020 OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2020 Oxford Biomedica plc
18-Sep-2020 NOVO VENTURES CO-LEADS US$83M SERIES C FINANCING IN LAVA THERAPEUTICS About Novo Holdings A/S
18-Sep-2020 PARTNERSHIP ACCELERATES DRUG DEVELOPMENT Quay Pharma
18-Sep-2020 Liverpool John Moores University gives students a Better insight into e-prescribing Liverpool John Moores University
18-Sep-2020 Chi-Med Announces Second NDA Acceptance in China for Surufatinib in Pancreatic Neuroendocrine Tumors Surufatinib
18-Sep-2020 Oxurion NV Business Update and First Half 2020 Financial Results to be announced on 17 September Oxurion
18-Sep-2020 Helsinn Group and Italfarmaco announce oral presentation of NEPA (netupitant and palonosetron) data at ESMO Virtual Congress 2020 Helsinn
18-Sep-2020 Positive pivotal data for Libtayo® (cemiplimab) monotherapy in locally advanced basal cell carcinoma featured as a late-breaking presentation at ESMO Regeneron Pharmaceuticals, Inc.
18-Sep-2020 UCB launches Community Health Fund to support vulnerable young people post-COVID-19 crisis UCB
18-Sep-2020 Lynparza improved median time patients lived without disease progression to over four and half years in BRCA-mutated advanced ovarian cancer vs. just over one year with placebo AstraZeneca
17-Sep-2020 PharmiWeb.Jobs Welcomes Northreach Northreach
17-Sep-2020 2020 PM Society Digital Awards - Winners Announced PM Society
15-Sep-2020 IDBS works with SCIEX to launch Analyst™ Software integration for enhanced regulatory compliance IDBS
15-Sep-2020 AMRYT RECEIVES POSITIVE OPINION FROM EMA ON ORPHAN DRUG DESIGNATION FOR AP103 Amryt
15-Sep-2020 Live Event: Recent Austrian Corona Measures Validate New euroPLX Concept RauCon
15-Sep-2020 Onyx Health Launches International PR Partnership with US Agency Jeff Winton Associates Onyx Health
15-Sep-2020 SHIONOGI LAUNCHES FETCROJA® (CEFIDEROCOL) IN THE UNITED KINGDOM FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH LIMITED TREATMENT OPTIONS Shionogi & Co., Ltd
15-Sep-2020 Royal Society of Chemistry’s journal archives now available to companies for Text and Data Mining The Royal Society of Chemistry
15-Sep-2020 Novartis reports positive topline results from the first Phase III trial of Beovu® versus aflibercept in patients with diabetic macular edema (DME) Novartis